Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN)
CUSIP: 51654W101
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 11,280,432
- Total 13F shares
- 1,152,036
- Share change
- +68,358
- Total reported value
- $6,497,253
- Put/Call ratio
- 100%
- Price per share
- $5.64
- Number of holders
- 25
- Value change
- +$385,814
- Number of buys
- 12
- Number of sells
- 8
Quarterly Holders Quick Answers
What is CUSIP 51654W101?
CUSIP 51654W101 identifies LTRN - Lantern Pharma Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 51654W101:
Top shareholders of LTRN - Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
3.3%
|
367,454
|
$1,774,803 | — | 31 Mar 2023 | |
| NewEdge Advisors, LLC |
13F
|
Company |
1.5%
|
172,115
|
$831,344 | — | 31 Mar 2023 | |
| Carlson Capital, L.P. |
13F
|
Company |
1.1%
|
124,900
|
$603,267 | — | 31 Mar 2023 | |
| CM Management, LLC |
13F
|
Company |
0.53%
|
60,000
|
$290,000 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.51%
|
57,774
|
$279,048 | — | 31 Mar 2023 | |
| Redmond Asset Management, LLC |
13F
|
Company |
0.44%
|
49,189
|
$237,583 | — | 31 Mar 2023 | |
| HORIZON KINETICS ASSET MANAGEMENT LLC |
13F
|
Company |
0.27%
|
30,000
|
$144,900 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.25%
|
27,752
|
$134,042 | — | 31 Mar 2023 | |
| UBS Group AG |
13F
|
Company |
0.24%
|
27,000
|
$130,410 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.23%
|
26,480
|
$127,898 | — | 31 Mar 2023 | |
| WOLFF WIESE MAGANA LLC |
13F
|
Company |
0.23%
|
26,478
|
$127,889 | — | 31 Mar 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.22%
|
24,600
|
$119,000 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.19%
|
21,450
|
$103,603 | — | 31 Mar 2023 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.18%
|
20,186
|
$97,000 | — | 31 Mar 2023 | |
| Sigma Planning Corp |
13F
|
Company |
0.15%
|
17,275
|
$83,438 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.11%
|
12,629
|
$60,998 | — | 31 Mar 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.1%
|
10,976
|
$53,014 | — | 31 Mar 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.04%
|
4,486
|
$21,667 | — | 31 Mar 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
2,117
|
$10,000 | — | 31 Mar 2023 | |
| Cranbrook Wealth Management, LLC |
13F
|
Company |
0.01%
|
717
|
$3,464 | — | 31 Mar 2023 | |
| Allworth Financial LP |
13F
|
Company |
0%
|
100
|
$483 | — | 31 Mar 2023 | |
| Franklyn G. Prendergast |
3/4/5
|
Director |
—
class O/S missing
|
3,200
|
— | — | 04 Nov 2021 |
Institutional Holders of Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) as of Q2 2023
As of 30 Jun 2023,
Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,152,036 shares.
The largest 10 holders included
VANGUARD GROUP INC, NewEdge Advisors, LLC, CARLSON CAPITAL L P, GEODE CAPITAL MANAGEMENT, LLC, CM Management, LLC, Redmond Asset Management, LLC, RENAISSANCE TECHNOLOGIES LLC, HORIZON KINETICS ASSET MANAGEMENT LLC, STATE STREET CORP, and UBS Group AG.
This page lists
25
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
21
Q2 2023 holders
25
Holder diff
4
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.